Ask AI
H.R. 4978

Nurturing And Supporting Healthy Babies Act

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

(Sec. 2) This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.

Specifically, the GAO shall report on:

  • the prevalence of NAS,
  • NAS treatment services for which coverage is available under state Medicaid programs,
  • the settings and associated reimbursement methodologies for NAS treatment,
  • the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment,
  • any federal barriers to treating infants with NAS under state Medicaid programs, and
  • best practices for treating infants with NAS.

The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.

(Sec. 3) The bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.

(Sec. 4) Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program. A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.

(Sec. 5) The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.

Received in the Senate and Read twice and referred to the Committee on Finance.

Rep. Jenkins, Evan H. [R-WV-3](R-WV)Sponsor
15 cosponsors5 D10 R
15cosponsors2committees21actions4related bills16subjects
  1. IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Finance.

    Finance Committee
  2. FloorH38800

    The title of the measure was amended. Agreed to without objection.

  3. FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  4. FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2259-2260)

  5. Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2259-2260)

  6. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 4978.

  7. FloorH30000

    Considered under suspension of the rules. (consideration: CR H2259-2263)

  8. FloorH30300

    Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

  9. CalendarsH12410

    Placed on the Union Calendar, Calendar No. 433.

  10. CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-559.

    Energy and Commerce Committee
  11. Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-559.

    Energy and Commerce Committee
  12. Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  13. Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  14. Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  15. Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  16. Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  17. Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  18. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  19. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  20. IntroReferralIntro-H

    Introduced in House

  21. IntroReferral1000

    Introduced in House

May 11, 201636

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

(Sec. 2) This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.

Specifically, the GAO shall report on:

  • the prevalence of NAS,
  • NAS treatment services for which coverage is available under state Medicaid programs,
  • the settings and associated reimbursement methodologies for NAS treatment,
  • the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment,
  • any federal barriers to treating infants with NAS under state Medicaid programs, and
  • best practices for treating infants with NAS.

The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.

(Sec. 3) The bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.

(Sec. 4) Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program. A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.

(Sec. 5) The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.

May 10, 201617

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

(Sec. 2) This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.

Specifically, the GAO shall report on:

  • the prevalence of NAS,
  • NAS treatment services for which coverage is available under state Medicaid programs,
  • the settings and associated reimbursement methodologies for NAS treatment,
  • the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, and
  • any federal barriers to treating infants with NAS under state Medicaid programs.

The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.

(Sec. 3) The bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.

(Sec. 4) Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program. A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.

(Sec. 5) The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.

Apr 18, 2016

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.

Specifically, the GAO shall report on:

  • the prevalence of NAS,
  • NAS treatment services for which coverage is available under state Medicaid programs,
  • the settings and associated reimbursement methodologies for NAS treatment,
  • the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, and
  • any federal barriers to treating infants with NAS under state Medicaid programs.

The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.

Nurturing And Supporting Healthy Babies Act — Informed